ONYX — Onyx Biotec Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapNeutral

Annual income statement for Onyx Biotec, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	PROSPECTUS	PROSPECTUS	PRESS
Standards:	IAS	IAS	IAS	—
Status:	Final	Final	Final	Final
Revenue
Total Revenue	449	395	537	620
Cost of Revenue
Gross Profit	183	185	180	228
Selling / General / Administrative Expenses
Depreciation and Amortization
Other Operating Expenses
Total Operating Expenses	407	365	477	547
Operating Profit	42	29.8	60.3	73
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	38	25.5	40.5	64.8
Provision for Income Taxes
Net Income After Taxes	33.5	18.4	30.3	49.5
Net Income Before Extraordinary Items
Net Income	33.5	18.4	30.3	49.5
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	33.5	18.4	30.3	49.5
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	1.85	1.02	1.67	3.3
Dividends per Share